KLP Kapitalforvaltning AS Makes New $1.89 Million Investment in Encompass Health Co. (NYSE:EHC)

KLP Kapitalforvaltning AS bought a new position in shares of Encompass Health Co. (NYSE:EHC - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 20,500 shares of the company's stock, valued at approximately $1,893,000.

A number of other hedge funds have also bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after buying an additional 137 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its stake in Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the last quarter. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the fourth quarter valued at about $46,000. V Square Quantitative Management LLC raised its stake in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock worth $54,000 after purchasing an additional 177 shares during the last quarter. Finally, Signaturefd LLC lifted its holdings in shares of Encompass Health by 21.6% during the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after purchasing an additional 125 shares during the period. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.10% of the stock is currently owned by corporate insiders.

Remove Ads

Analysts Set New Price Targets

EHC has been the topic of several research reports. StockNews.com upgraded shares of Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Royal Bank of Canada reissued an "outperform" rating and set a $110.00 target price on shares of Encompass Health in a report on Tuesday, February 11th. Barclays boosted their target price on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. KeyCorp lifted their price objective on Encompass Health from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Monday, February 10th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a research note on Friday, February 7th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health presently has a consensus rating of "Buy" and a consensus price target of $107.67.

Encompass Health Price Performance

NYSE EHC traded down $0.01 during trading hours on Tuesday, reaching $101.27. The company's stock had a trading volume of 486,266 shares, compared to its average volume of 645,880. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 1-year low of $78.53 and a 1-year high of $104.55. The company's 50-day moving average is $98.92 and its two-hundred day moving average is $97.58. The firm has a market capitalization of $10.20 billion, a price-to-earnings ratio of 22.71, a P/E/G ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, equities analysts predict that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a dividend of $0.17 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.67%. Encompass Health's dividend payout ratio (DPR) is presently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.